HK inno.N Corporation (KOSDAQ:195940)

South Korea · Delayed Price · Currency is KRW

54,000

-1,100 (-2.00%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
HB&B Division	65.77B	81.21B	73.00B	62.45B
HB&B Division Growth	-19.01%	11.23%	16.91%	-
Prescription Drugs Business	704.02B	517.24B	466.89B	428.25B
Prescription Drugs Business Growth	36.11%	10.78%	9.02%	-
Other	-	3.00M	12.00M	-
Other Growth	-	-75.00%	-	-
Total	769.79B	598.45B	539.91B	490.70B
Total Growth	28.63%	10.84%	10.03%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Korea	734.44B	567.90B	515.02B	465.61B
Korea Growth	29.33%	10.27%	10.61%	-
Japan	9.66B	12.61B	11.93B	12.88B
Japan Growth	-23.42%	5.70%	-7.34%	-
United States of America	4.08B	1.13B	1.49B	1.05B
United States of America Growth	262.33%	-24.38%	41.39%	-
Other	21.61B	16.81B	11.47B	11.16B
Other Growth	28.54%	46.58%	2.78%	-
Total	769.79B	598.45B	539.91B	490.70B
Total Growth	28.63%	10.84%	10.03%	-

Source: S&P Global Market Intelligence.